Found "Health Policies": 1,084 results
Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage.
Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca
Siriyada Kitbamrung
Siriyada is a dedicated research assistant at MIDAS, holds a graduate degree in Pharmaceutical Sciences with a specialization in social and administrative pharmacy. Her commitment lies in optimizing healthcare systems utilizing evidence-based evaluation of health technology from their inception and expanding patient access to these interventions.
Puwadol Chawengkul
Puwadol Chawengkul is a research assistant with a research focus on data science. He is passionate about the potential of data science to enhance insightful knowledge in public health policy, leading to better decision-making and healthier communities.
The development of health technology assessment on the drug selection for the National List of Essential Medicines (NLEM)
66203067RM019L0Monitoring and evaluation of high cost medicines,National List of Essential Medicines,Thailand
โครงการประเมินสถานการณ์ด้านนโยบายการป้องกันและควบคุมโรคเพื่อจัดตั้งศูนย์ควบคุมโรคติดต่อประจำภูมิภาคเอเชียตะวันออกเฉียงใต้
COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e
10 / Page